Photodynamic therapy-triggered nuclear translocation of berberine from mitochondria leads to liver cancer cell death

Abstract

Berberine, a traditional Chinese herbal compound, is known for its broad range of biological activities, including anticancer and phototoxic effects. However, the precise mechanisms underlying its phototoxicity in liver cancer cells remain unclear. In this study, we investigated the potential of berberine as a photosensitizer for photodynamic therapy (PDT) by examining its phototoxic effects under blue light irradiation (488 nm). The results showed that berberine rapidly translocated from the mitochondria to the nucleus upon light exposure, ultimately inducing cell death in SNU449 and Huh7 cells. Additionally, we observed a significant increase in reactive oxygen species, linking the phototoxic effects to oxidative stress. EdU/DAPI staining further revealed a marked reduction in DNA replication, with a complete absence of SNU449 cells in the S phase, indicating cell cycle arrest following treatment with berberine and PDT. Transcriptomic analysis also showed extensive gene expression changes, with GO enrichment indicating altered chromatin accessibility and cellular stress response following berberine and PDT combination therapy. qPCR and Western blotting confirmed that ER stress was significantly induced, triggering the activation of the pro-apoptotic protein DDIT3, which contributes to berberine-PDT-induced cell death. These findings underscore the potential of berberine as a photosensitizer and provide a promising approach for enhancing liver cancer treatment using PDT.

References

[1] Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J. Photodynamic therapy of cancer: An update. CA: A Cancer Journal for Clinicians, 2011, 61(4): 250-281.

[2] Aleissa MS, Al-Zharani M, Alneghery LM, Aleissa AM. Berberine enhances the sensitivity of radiotherapy in ovarian cancer cell line (SKOV-3). Saudi Pharmaceutical Journal, 2023, 31(1): 110-118.

[3] An YW, Jin HT, Yuan B, Wang JC, Wang C, Liu HQ. Research progress of berberine mediated photodynamic therapy. Oncology Letters, 2021, 21(5): 359. 7967931

[4] Cao T, Luo X, Zheng B, Deng Y, Zhang Y, Li Y, Xi W, Guo M, Yang X, Li Z, Lu B. Death-associated protein 3 in cell death and beyond. Genome Instability & Disease, 2024, 5(2): 51-60.

[5] Carriero F, Martinelli C, Gabriele F, Barbieri G, Zanoletti L, Milanesi G, Casali C, Azzalin A, Manai F, Paolillo M, Comincini S. Berberine photo-activation potentiates cytotoxicity in human astrocytoma cells through apoptosis induction. Journal of Personalized Medicine, 2021, 11(10): 942. 8541605

[6] Devarajan N, Nathan J, Mathangi R, Mahendra J, Ganesan SK. Pharmacotherapeutic values of berberine: A Chinese herbal medicine for the human cancer management. Journal Of Biochemical And Molecular Toxicology, 2023, 37(3): e23278.

[7] Fang J, Huang X, Yang Y, Wang X, Liang X, Liu J. Berberine-photodynamic induced apoptosis by activating endoplasmic reticulum stress-autophagy pathway involving CHOP in human malignant melanoma cells. Biochemical and Biophysical Research Communications, 2021, 552: 183-190.

[8] Fengchao C, Siya Z, Tongtong Y, Hongquan W, Jie L, Qiang W, Danish S, Kun L. The enhanced cytotoxicity on breast cancer cells by Tanshinone I-induced photodynamic effect. Scientific Reports, 2023, 13(1): 18107. 10593796

[9] Hamsa TP, Kuttan G. Berberine inhibits pulmonary metastasis through down-regulation of MMP in metastatic B16F-10 melanoma cells. Phytotherapy Research, 2012, 26(4): 568-578.

[10] Hetz C, Papa FR. The unfolded protein response and cell fate control. Molecular Cell, 2018, 69(2): 169-181.

[11] Hirakawa K, Hirano T, Nishimura Y, Arai T, Nosaka Y. Dynamics of singlet oxygen generation by DNA-binding photosensitizers. The Journal of Physical Chemistry B, 2012, 116(9): 3037-3044.

[12] Jiang W, Liang M, Lei Q, Li G, Wu S. The current status of photodynamic therapy in cancer treatment. Cancers (Basel), 2023, 15(3): 585.

[13] Kumar A, Ekavali, Chopra K, Mukherjee M, Pottabathini R, Dhull DK. Current knowledge and pharmacological profile of berberine: An update. European Journal of Pharmacology, 2015, 761: 288-297.

[14] Li G, Zhang C, Liang W, Zhang Y, Shen Y, Tian X. Berberine regulates the Notch1/PTEN/PI3K/AKT/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells. Pharmaceutical Biology, 2021, 59(1): 21-30. 7808376

[15] Lin HJ, Ho JH, Tsai LC, Yang FY, Yang LL, Kuo CD, Chen LG, Liu YW, Wu JY. Synthesis and in vitro photocytotoxicity of 9-/13-lipophilic substituted berberine derivatives as potential anticancer agents. Molecules, 2020, 25(3): 677. 7036939

[16] Liu HQ, An YW, Hu AZ, Li MH, Cui GH. Photodynamic therapy enhanced the antitumor effects of berberine on hela cells. Open Chemistry, 2019, 17(1): 413-421.

[17] Lopes TZ, de Moraes FR, Tedesco AC, Arni RK, Rahal P, Calmon MF. Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells. Biomedicine & Pharmacotherapy, 2020, 123: 109794.

[18] Luiza Andreazza N, Vevert-Bizet C, Bourg-Heckly G, Sureau F, José Salvador M, Bonneau S. Berberine as a photosensitizing agent for antitumoral photodynamic therapy: Insights into its association to low density lipoproteins. International Journal of Pharmaceutics, 2016, 510(1): 240-249.

[19] Majidzadeh H, Araj-Khodaei M, Ghaffari M, Torbati M, Ezzati Nazhad Dolatabadi J, Hamblin MR. Nano-based delivery systems for berberine: A modern anti-cancer herbal medicine. Colloids and Surfaces. B, Biointerfaces, 2020, 194: 111188.

[20] Mukherjee A, Ghosh KK, Chakrabortty S, Gulyás B, Padmanabhan P, Ball WB. Mitochondrial reactive oxygen species in infection and immunity. Biomolecules, 2024, 14(6): 670. 11202257

[21] Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA, Soerjomataram I. Global burden of primary liver cancer in 2020 and predictions to 2040. Journal of Hepatology, 2022, 77(6): 1598-1606. 9670241

[22] Samad MA, Saiman MZ, Abdul Majid N, Karsani SA, Yaacob JS. Berberine inhibits telomerase activity and induces cell cycle arrest and telomere erosion in colorectal cancer cell line, HCT 116. Molecules, 2021, 26(2): 376. 7828342

[23] Sano R, Reed JC. ER stress-induced cell death mechanisms. Biochimica Et Biophysica Acta, 2013, 1833(12): 3460-3470.

[24] Tang R, Xu J, Zhang B, Liu J, Liang C, Hua J, Meng Q, Yu X, Shi S. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. Journal of Hematology & Oncology, 2020, 13(1): 110.

[25] Tong N, Zhang J, Chen Y, Li Z, Luo Y, Zuo H, Zhao X. Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro. Oncology letters, 2012, 3(6): 1263-1267. 3392583

[26] Torrini C, Nguyen TTT, Shu C, Mela A, Humala N, Mahajan A, Seeley EH, Zhang G, Westhoff MA, Karpel-Massler G, Bruce JN, Canoll P, Siegelin MD. Lactate is an epigenetic metabolite that drives survival in model systems of glioblastoma. Molecular Cell, 2022, 82(16): 3061-3076e3066. 9391294

[27] Tuo J, Xie Y, Song J, Chen Y, Guo Q, Liu X, Ni X, Xu D, Huang H, Yin S, Zhu W, Wu J, Hu H. Development of a novel berberine-mediated mitochondria-targeting nano-platform for drug-resistant cancer therapy. Journal of Materials Chemistry B, 2016, 4(42): 6856-6864.

[28] Wang MX, Huo LM, Yang HC, Gao YJ, E Z. An experimental study on the photodynamic activity of berberine in vitro on cancer cells. Journal of Traditional Chinese Medicine, 1986, 6(2): 125-127

[29] Wang HF, Wang ZQ, Ding Y, Piao MH, Feng CS, Chi GF, Luo YN, Ge PF. Endoplasmic reticulum stress regulates oxygen-glucose deprivation-induced parthanatos in human SH-SY5Y cells via improvement of intracellular ROS. CNS Neuroscience & Therapeutics, 2018, 24(1): 29-38.

[30] Wei W, Li Y, Wang C, Gao S, Zhao Y, Yang Z, Wang H, Gao Z, Jiang Y, He Y, Zhao L, Gao H, Yao X, Hu Y. Diterpenoid Vinigrol specifically activates ATF4/DDIT3-mediated PERK arm of unfolded protein response to drive non-apoptotic death of breast cancer cells. Pharmacological Research, 2022, 182: 106285.

[31] Yang L, Cao J, Wei J, Deng J, Hou X, Hao E, Du Z, Zou L, Li P. Antiproliferative activity of berberine in HepG2 cells via inducing apoptosis and arresting cell cycle. Food & Function, 2021, 12(23): 12115-12126.

[32] You X, Cao X, Lin Y. Berberine enhances the radiosensitivity of hepatoma cells by Nrf2 pathway. Front Biosci (Landmark Ed), 2019, 24(7): 1190-1202.

[33] Zhang M, Liu J, Yu C, Tang S, Jiang G, Zhang J, Zhang H, Xu J, Xu W. Berberine regulation of cellular oxidative stress, apoptosis and autophagy by modulation of m(6)A mRNA methylation through targeting the camk1db/ERK pathway in zebrafish-hepatocytes. Antioxidants (Basel), 2022, 11(12): 2370.

[34] Zhao Y, Jing Z, Li Y, Mao W. Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis. Oncology Reports, 2016, 36(1): 567-572.

[35] Zou H, Wang F, Zhou JJ, Liu X, He Q, Wang C, Zheng YW, Wen Y, Xiong L. Application of photodynamic therapy for liver malignancies. Journal of Gastrointestinal Oncology, 2020, 11(2): 431-442. 7212095

Funding

Shenzhen Natural Science Fund,(20220810151804002)

Innovative Research Group Project of the National Natural Science Foundation of China(82273291)

Sanming Project of Medicine in Shenzen Municipality(SZSM202003009)

HaiYa Young Scientist Foundation of Shenzhen University General Hospital,(2024-HY008)

RIGHTS & PERMISSIONS

Shenzhen University School of Medicine; Fondazione Istituto FIRC di Oncologia Molecolare